An Overlooked Issue: Prostate Cancer in Transgender Women
TUESDAY, May 2, 2023 (HealthDay News) — Transgender women have a risk of prostate cancer, even after gender-affirming surgeries, yet aren’t “on the radar” for screening by clinicians, new research finds.”The entire medical literature on prostate canc…
Learn MoreWestern Diet May Have Detrimental Effect on Prostate Cancer Risk
WEDNESDAY, April 19, 2023 (HealthDay News) — Adherence to a Western diet may have a detrimental effect on the risk for prostate cancer, according to a study published online April 19 in BJU International.Adela Castelló, Ph.D., from the University of …
Learn MoreAddition of Metastasis-Directed Therapy Increases PFS in Prostate Cancer
THURSDAY, April 13, 2023 (HealthDay News) — The addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival for men with oligometa…
Learn MoreGermline Genetic Testing Feasible for Advanced Prostate Cancer
WEDNESDAY, April 12, 2023 (HealthDay News) — Germline genetic testing followed by consultation with a genetic counselor is clinically impactful and yields high satisfaction for patients with advanced prostate cancer, according to a study published in…
Learn MoreGuideline Updated for Initial Management of Advanced Prostate Cancer
WEDNESDAY, April 12, 2023 (HealthDay News) — For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT),…
Learn MoreLa mayoría de los hombres con un cáncer de próstata de bajo riesgo prescinden ahora de una cirugía inmediata
MARTES, 4 de abril de 2023 (HealthDay News) — En la última década, cada vez más estadounidenses con un cáncer de próstata temprano han postergado la radiación y la cirugía, las opciones estándar de tratamiento, indica una nueva investigación.Más bien…
Learn MoreMost Men With Low-Risk Prostate Cancers Now Forgo Immediate Surgery
TUESDAY, April 4, 2023 (HealthDay News) — Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.Instead, many U.S. men with low- or in…
Learn MoreInitiating Salvage RT When PSA >0.25 ng/mL Linked to All-Cause Mortality
FRIDAY, March 31, 2023 (HealthDay News) — For men with one high-risk factor, initiating post-radical prostatectomy salvage radiation therapy (sRT) when prostate-specific antigen (PSA) levels are greater than 0.25 ng/mL is associated with an increased…
Learn MoreLong-Term Waterborne-Ingested Nitrate Linked to Prostate Cancer Risk
WEDNESDAY, March 29, 2023 (HealthDay News) — Long-term waterborne-ingested nitrate is associated with an increased risk for prostate cancer, especially aggressive tumors, according to a study published online March 8 in Environmental Health Perspecti…
Learn MoreClinical Utility Poor for Prostate Cancer Germline Panels in African Men
FRIDAY, March 24, 2023 (HealthDay News) — For men of African ancestry, currently utilized germline testing panels for prostate cancer have poor clinical utility, with clinical value in only 30 percent of current gene panels, according to a study publ…
Learn More